Purchases and Sales Made in Q4 2023 in Kiniksa Pharmaceuticals, Ltd. (KNSA)
This table provides information about the institutional ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA) during Q4 2023. The information is specifically focused on institutions that hold shares of Kiniksa Pharmaceuticals, Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 25, 2024
Q4 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-9.92K- 16.12% |
$142K - $189K
|
51.6K
$1.19M
|
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-12.9K- 4.07% |
$186K - $246K
|
305K
$7.03M
|
|
|
Feb 07, 2024
Q4 2023
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-14K- 7.51% |
$201K - $266K
|
172K
$3.97M
|
|
|
Feb 08, 2024
Q4 2023
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-14.3K- 2.2% |
$206K - $273K
|
636K
$14.7M
|
|
|
Mar 21, 2024
Q4 2023
|
Healthcare Of Ontario Pension Plan Trust Fund
Toronto, A6 |
SELL
|
- |
-15K- 6.19% |
$216K - $286K
|
228K
$5.25M
|
|
|
Feb 13, 2024
Q4 2023
|
Envestnet Asset Management Inc
|
SELL
|
- |
-17.7K- 54.92% |
$254K - $337K
|
14.5K
$335K
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
- |
-17.8K- 27.74% |
$256K - $339K
|
46.4K
$1.07M
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-23.4K- 68.81% |
$336K - $446K
|
10.6K
$245K
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-24K- 6.41% |
$344K - $457K
|
350K
$8.08M
|
|
|
Feb 14, 2024
Q4 2023
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-27.7K- 54.89% |
$398K - $528K
|
22.8K
$526K
|
|
|
Feb 13, 2024
Q4 2023
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-29K- 14.59% |
$417K - $554K
|
170K
$3.93M
|
|
|
Feb 14, 2024
Q4 2023
|
Alps Advisors Inc
Denver, CO |
SELL
|
- |
-29.2K- 41.08% |
$420K - $557K
|
41.9K
$967K
|
|
|
Feb 13, 2024
Q4 2023
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-33.9K- 2.11% |
$487K - $646K
|
1.57M
$36.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-41.7K- 45.2% |
$599K - $795K
|
50.5K
$1.17M
|
|
|
Feb 13, 2024
Q4 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-43.3K- 31.09% |
$622K - $825K
|
95.9K
$2.21M
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-50.2K- 24.27% |
$722K - $958K
|
157K
$3.62M
|
|
|
Feb 14, 2024
Q4 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-87.5K- 28.93% |
$1.26M - $1.67M
|
215K
$4.96M
|
|
|
Feb 14, 2024
Q4 2023
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-95.5K- 29.52% |
$1.37M - $1.82M
|
228K
$5.27M
|
|
|
Feb 12, 2024
Q4 2023
|
Gmt Capital Corp
Atlanta, GA |
SELL
|
- |
-136K- 28.52% |
$1.96M - $2.6M
|
342K
$7.89M
|
|
|
Feb 13, 2024
Q4 2023
|
Advisory Research Inc
Chicago, IL |
SELL
|
- |
-139K- 67.93% |
$1.99M - $2.64M
|
65.5K
$1.51M
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-153K- 27.11% |
$2.2M - $2.92M
|
411K
$9.49M
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-165K- 72.83% |
$2.37M - $3.14M
|
61.4K
$1.42M
|
|
|
Feb 13, 2024
Q4 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-170K- 5.52% |
$2.44M - $3.24M
|
2.91M
$67.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-174K- 82.86% |
$2.49M - $3.31M
|
35.9K
$829K
|
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-182K- 52.35% |
$2.61M - $3.46M
|
165K
$3.82M
|
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-200K- 94.05% |
$2.87M - $3.81M
|
12.6K
$292K
|
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-216K- 12.24% |
$3.1M - $4.11M
|
1.55M
$35.7M
|
|
|
Feb 14, 2024
Q4 2023
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
SELL
|
- |
-270K- 27.44% |
$3.88M - $5.15M
|
715K
$16.5M
|